Concepedia

Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy

Anbok Lee, Sunmi Jo, Changhu Lee, Hyun‐Hee Shin, Tae Hyun Kim, Ki Jung Ahn, Sung-Kwang Park, Heunglae Cho, Hye-Kyoung Yoon, Woo Gyeong Kim,

Breast Cancer · 2019 · 16 citations · 18 references

DOI

Concepts

References

18

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks et al. · Journal of Clinical Oncology · 2013 · 4.1K citations · Full text

, , +14

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Aron Goldhirsch, W. C. Wood, Alan S. Coates et al. · Annals of Oncology · 2011 · 3.9K citations · Full text

, , +16

Diabetes and Cancer

Edward L. Giovannucci, David M. Harlan, Michael C. Archer et al. · Diabetes Care · 2010 · 2.2K citations · Full text

, , +14

The Neuregulin-I/ErbB Signaling System in Development and Disease

Stefan Britsch · Advances in anatomy, embryology and cell biology · 2007 · 246 citations

, , +7

Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients

Sao Jiralerspong, E. S. Kim, Wenli Dong et al. · Annals of Oncology · 2013 · 168 citations · Full text

, , +10